ResMed Inc. RMD
222.00
0.11
0.05%
as of 25 Sep
- Market cap
- $31.9B
- P/E
- 21.3×
Follow RMD
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
ResMed Inc. (RMD) Revenue growth
ResMed Inc.'s revenue growth over the twelve months to 30 June 2026 was 9.85%. Over the past ten years it has ranged from 7.97% (fiscal 2015) to 18.0% (fiscal 2023); the current reading is higher than 42% of that period. That is above the Medical Instruments & Supplies industry median of 9.20% and above the Healthcare sector median of 8.26%.
Revenue growth, annual
Annual
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2026 | 9.85% | 0.01 |
| FY2025 | 9.84% | (1.11) |
| FY2024 | 11.0% | (7.07) |
| FY2023 | 18.0% | 6.09 |
| FY2022 | 11.9% | 3.82 |
| FY2021 | 8.11% | (5.33) |
| FY2020 | 13.4% | 2.06 |
| FY2019 | 11.4% | (1.85) |
| FY2018 | 13.2% | 0.83 |
| FY2017 | 12.4% | 2.88 |
Quarterly
| Period | Revenue growth | Change (points) |
|---|---|---|
| Jun 2026 | 8.58% | (2.23) |
| Mar 2026 | 10.8% | (0.17) |
| Dec 2025 | 11.0% | 1.91 |
| Sep 2025 | 9.07% | (1.13) |
| 42 more quarters | Free account |
Against its own ten years
Low 7.97%
High 18.0%
Ten-year median
11.2%
Current reading's percentile
42
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| RGEN Repligen Corporation compare | 16.5% |
| BDX Becton, Dickinson and Company compare | 13.1% |
| WST West Pharmaceutical Services, Inc. compare | 12.4% |
| RMD ResMed Inc. | 9.85% |
| ALC Alcon compare | 8.34% |
| BAX Baxter International Inc. compare | 5.36% |
| COO The Cooper Companies, Inc. compare | 4.73% |
| SOLV Solventum Corporation compare | −0.93% |
| MDLN Medline Inc. compare | — |
| Medical Instruments & Supplies industry median | 9.20% |
| Healthcare sector median | 8.26% |
| Market median | 7.41% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on RMD
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- The full statement